For citations:
Korbut A.I., Romanov V.V., Klimontov V.V. Effects of empagliflozin on biomarkers of renal injury, fibrosis and low-grade inflammation in patients with type 2 diabetes. Diabetes mellitus. 2025;28(6):550-557. (In Russ.) https://doi.org/10.14341/DM13350
Views PDF (Rus): 0
JATS XML
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
